Characterizing vascular parameters in hypoxic regions: A combined magnetic resonance and optical imaging study of a human prostate cancer model

Cancer Research

Volumn 66, Issue 20, 2006, Pages 9929-9936

  Raman, Venu ^a   Artemov, Dmitri ^a   Pathak, Arvind P ^a   Winnard Jr , Paul T ^a   McNutt, Stephen ^a   Yudina, Anna ^b   Bogdanov Jr , Alexei ^b   Bhujwalla, Zaver M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; LECTIN; VASCULOTROPIN;

ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; GENETIC ENGINEERING; HUMAN; HUMAN CELL; HYPOXIA; IMAGING SYSTEM; IMMUNOFLUORESCENCE TEST; MOLECULAR CLONING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; SOLID TUMOR; TOMATO; VASCULARIZATION;

ANIMALS; CELL HYPOXIA; CELL LINE, TUMOR; GREEN FLUORESCENT PROTEINS; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MICE; MICE, SCID; OXYGEN; PLANT LECTINS; PROSTATIC NEOPLASMS; RESPONSE ELEMENTS; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33750569401     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-0886     Document Type: Article

References (23)

1. Harrison L. Blackwell K. Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy? Oncologist, 2004;9:31-40.
2. Thomlinson RH, Gray LH. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 1955;9:539-49.
3. Brizel DM, Scully SP, Harrelson JM, et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 1996;56:941-3.
4. Jordan BF, Runquist M, Raghunand N. et al. Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1α using PX-478. Neoplasia 2005;7:475-85.
5. Greijer AE, van der Groep P, Kemming D, et al. Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1). J Pathol 2005;206:291-304.
6. Shibata T, Giaccia AJ, Brown JM. Development of a hypoxia-responsive vector for tumor-specific gene therapy. Gene Ther 2000;7:493-8.
7. Bhujwalla ZM, Artemov D, Natarajan K, Ackerstaff F., Solaiyappan M. Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts. Neoplasia 2001;3:143-53.
8. Yuan Y, Hilliard G, Ferguson T, Millhorn DE. Cobalt inhibits the interaction between hypoxia-inducible factor-α and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-α. J Biol Chem 2003;278:15911-6. Epub 2003 Feb 26.
9. Thevenaz P, Ruttiman UE, Unser M. A pyramid approach to subpixel registration based on intensity. IEEE Trans Image Process 1998;7:27-41.
10. Atkins DJ, Gingert C, Justenhoven C, et al. Concomitant deregulation of HIF1α and cell cycle proteins in VHL-mutated renal cell carcinomas. Virchows Arch 2005;447:634-42. Epub 2005 Jul 1.
11. Wang Z, Su MY, Nalcioglu O. Applications of dynamic contrast enhanced MRI in oncology: measurement of tumor oxygen tension. Technol Cancer Res Treat 2002;1:29-38.
12. Zhao D, Jiang L, Mason RP. Measuring changes in tumor oxygenation. Methods Enzymol 2004;386:378-418.
13. Egeland TA, Gaustad JV, Vestvik IK, Benjaminsen IC, Mathiesen B, Rofstad EK. Assessment of fraction of radiobiologically hypoxic cells in human melanoma xenografts by dynamic contrast-enhanced MRI. Magn Reson Med 2006;55:874-82.
14. Brahimi-Horn MC, Pouyssegur J. The hypoxia-inducible factor and tumor progression along the angiogenic pathway. Int Rev Cytol 2005;242:157-213.
15. Lanzen J, Braun RD, Klitzman B, Brizel D, Secomb TW, Dewhirst MW. Direct demonstration of instabilities in oxygen concentrations within the extravascular compartment of an experimental tumor. Cancer Res 2006;66:2219-23.
16. Goerges AL, Nugenl MA. Regulation of vascular endothelial growth factor binding and activity by extracellular pH. J Biol Chem 2003;278:19518-25. Epub 2003 Mar 11.
17. Cao Y, Li CY, Moeller BJ, et al. Observation of incipient tumor angiogenesis that is independent of hypoxia and hypoxia inducible factor-1 activation. Cancer Res 2005;65:5498-505.
18. Serganova I, Doubrovin M, Vider J, et al. Molecular imaging of temporal dynamics and spatial heterogeneity of hypoxia-inducible factor-1 signal transduction activity in tumors in living mice. Cancer Res 2004;64:6101-8.
19. Raleigh JA, Chou SC, Arteel GE, Horsman MR. Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors. Radiat Res 1999;151:580-9.
20. Coralli C, Cemazar M, Kanthou C, Tozer GM, Dachs GU. Limitations of the reporter green fluorescent protein under simulated tumor conditions. Cancer Res 2001;61:4784-90.
21. Treins C, Giorgetti-Peraldi S, Murdaca J, Monthouel-Kartmann MN, Van Obberghen E. Regulation of hypoxia-inducible factor (HIF)-1 activity and expression of HIF hydroxylases in response to insulin-like growth factor I. Mol Endocrinol 2005;19:1304-17. Epub 2005 Feb 3.
22. Mizukami Y, Jo WS, Duerr EM, et al. Induction of interleukin-8 preserves the angiogenic response in HIF-1α-deficient colon cancer cells. Nat Med 2005;11:992-7. Epub 2005 Aug 28.
23. Manders P, Sweep FC, Tjan-Heijnen VC, et al. Vascular endothelial growth factor independently predicts the efficacy of postoperative radiotherapy in node-negative breast cancer patients. Clin Cancer Res 2003;9:6363-70.